Biohealthmatics.com The 24th annual conference TEPR 2008 will open its doors on May 19, 2008 at the Fort Lauderdale Convention Center to more than 500 speakers, close to 5,000 attendees, and approximately 200 exhibitors.
advertisement
Sign Up  
Biohealthmatics Centers
Home
Jobs Search
Career Center
Networking Center
Company Profiles
Knowledge Center
Industry News
Web Directory
Industry Books
Featured Articles

Biohealthmatics.com....linking professionals
advertisement

Join Us

Link To Us





Jobs Search Home - Companies Categories



Celgene Corporation
Address: 86 Morris Avenue
Summit
NJ
United States
07901
Phone Number: 908-673-9000
Website: http://www.celgene.com
Year Founded: 1986
Ownership: Public – CELG (NASDAQ)

Company Overview:
Celgene is a pharmaceutical company that is primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immunological diseases through regulation of genomic and proteomic targets.

Since its inception in 1986, Celgene has grown into an international and diverse company and along the way has acquired for important subsidiaries. On August 31, 2000, it acquired Signal Pharmaceuticals, Inc., a privately held San Diego-based biopharmaceuticals company focused on the discovery and development of drugs that regulate genes associated with diseases. It also acquired, on December 31, 2002, Anthrogenesis Corporation, a privately held New Jersey based biotherapeutics company and cord blood banking business, which has also pioneered the recovery of stem cells from human placental tissue following the completion of a full-term, successful pregnancy. Anthrogenesis now operates as Celgene Cellular Therapeutics (“CCT”), a wholly owned subsidiary.

The Company, together with these diverse subsidiaries, has built a commercialization, development, and discovery platform for drug and cell-based therapies that allows us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases.

Products and Services:
Celgene’s products include THALOMID® (thalidomide), ALKERAN® (melphalan), FOCALINTM (dexmethylphenidate HCl), cellular and tissue therapeutics, as well as the Ritalin® family of drugs. Celgene also produces compounds such as Benzopyrans and Selective Estrogen Receptor Modulators, Kinases Inhibitors, Tubulin Inhibitors, and Ligase Modulators.

Key Personnel Facts:
Celgene has over 750 employees as of 2005.

Key Financial Facts:
Total revenue for 2004 was 377 million USD.


Back to Top



Working @ Celgene Corporation
Have your shout about working or interveiwing at Celgene Corporation

1 message posted

Message Posted:

Working @ Celgene
Share your experiences about working, interviewing or applying for a job at ...
Author: Obi Posted: 10/10/2005 7:22:55 AM

View or add comments about Celgene Corporation

Back to Top


Celgene Corporation in the News

View more news about Celgene Corporation

Back To Top

 

Categories:

Biotechnology

 

Back to Top


 

 

   
Copyright © 2007 Biohealthmatics.com. All Rights Reserved. Contact Us - About Us - Privacy Policy - Terms & Conditions - Resources
Can't find what you are looking for? View our Site Map

Last Updated: 28 December 2007.